inflammatory diseases

Odyssey saga continues with $213M series D

The haul will finance clinical proof-of-concept studies across several of Odyssey's internally developed programs as well as support preclinical work.

Darren Incorvaia Sep 10, 2025 8:00am

Fosun rises again, beaming up 3rd biotech deal in 3 weeks

Aug 29, 2025 10:05am

Graphic image of two hands shaking with employeesexecutives on the forearms of each shaking hand

Sitala seals $670M deal for Fosun immune disease drug

Aug 26, 2025 2:44pm

Celldex ends esophageal program despite hitting primary endpoint

Aug 20, 2025 6:42am

Aerial view of karst mountains and sky clouds natural landscape at sunrise in Guilin China

Expedition inks $645M Fosun deal to bring China asset to US

Aug 11, 2025 11:06am

Rapt Tx cuts staff for 2nd time in less than a year

Jun 4, 2025 4:46pm